Full Breakdown
U.S. Adds Three Chinese Genomics Firms to Forced-Labor Entity List
By Drooid · · How we work
In this breakdown
01
Core Action and Companies Involved
On October 28, the United States prohibited imports from three Chinese genomics firms after the Department of Homeland Security placed them on the Uyghur Forced Labor Prevention Act Entity List. The entities are BGI Genomics Co. Ltd (stock code 300676.SZ), MGI Tech Co. Ltd (688114.SS), and Shenzhen BGI Technology Co. Ltd, also known as the BGI Group.
02
Legislative Background
The Uyghur Forced Labor Prevention Act, enacted in 2021, authorizes the Treasury’s Office of Foreign Assets Control to identify and restrict entities that are found to use or facilitate forced labor of Uyghurs or other minorities, or that source materials from China’s Xinjiang region. Inclusion on the Act’s Entity List effectively blocks the affected companies from exporting goods to the United States.
03
Official Rationale
U.S. The Department of Homeland Security’s announcement linked the companies’ operations to the alleged labor practices in Xinjiang, triggering the import ban under the Act’s provisions.
04
Chinese Government Response
Beijing has repeatedly rejected claims of forced-labor abuses in Xinjiang. Chinese officials described the U.S. accusations as unfounded and asserted that the allegations lack factual basis.
05
Anticipated Impact
The ban restricts U.S. laboratories and research institutions from purchasing sequencing equipment, reagents, and related services supplied by the listed firms. Analysts note that the restriction could pressure the companies to alter supply chains or face reduced market access in the United States, though the immediate economic effect remains to be quantified.